Health - Google News: FDA Reviewers Recommend Approval For Lomitapide For Homozygous Familial ... - Forbes

Health - Google News Google News

FDA Reviewers Recommend Approval For Lomitapide For Homozygous Familial ... - Forbes Oct 17th 2012, 20:26 French Tribune FDA Reviewers Recommend Approval For Lomitapide For Homozygous Familial ... Forbes The FDA Endocrinologic and Metabolic Drugs Advisory Committee voted 13-2 to recommend approval of Aegerion Pharmaceuticals' cholesterol-lowering drug lomitapide for use in patients with homozygous familial hypercholesterolemia (FH). The lopsided ... Safety Issues Raised over ISIS' DrugZacks.com Aegerion Shares Rise on Report of High Cholesterol DrugBloomberg PropThink: Safety Concerns with Kynamro Battering ISIS Ahead of Advisory ...Reuters Wall Street Journal -Businessweek -FierceBiotech all 86 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: